Have a feature idea you'd love to see implemented?
Let us know!
GLTO Galecto Inc
Price (delayed)
$5.845
Market cap
$7.7M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$19.14
Enterprise value
-$11.98M
Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer.
Highlights
The quick ratio has soared by 129% YoY and by 31% from the previous quarter
Galecto's debt has plunged by 100% YoY
GLTO's equity is down by 44% year-on-year and by 11% since the previous quarter
Key stats
What are the main financial stats of GLTO
Market
Valuations
Earnings
Shares outstanding
1.32M
Market cap
$7.7M
Enterprise value
-$11.98M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.3
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$21.12M
EBITDA
-$20.66M
Free cash flow
-$25.08M
Per share
Balance sheet
Liquidity
EPS
-$19.14
Free cash flow per share
-$21.9
Book value per share
$19.29
Revenue per share
$0
TBVPS
$20.42
Total assets
$23.38M
Total liabilities
$2.44M
Debt
$0
Equity
$20.94M
Working capital
$18.74M
Debt to equity
0
Current ratio
8.68
Quick ratio
8.06
Net debt/EBITDA
0.95
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-69.8%
Return on equity
-80.6%
Return on invested capital
-421.4%
Return on capital employed
-100.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GLTO stock price
How has the Galecto stock price performed over time
Intraday
0.6%
1 week
-15.53%
1 month
-16.86%
1 year
-58.63%
YTD
-67.53%
QTD
-51.89%
Financial performance
How have Galecto's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$21.83M
Net income
-$21.17M
Gross margin
N/A
Net margin
N/A
GLTO's net income has surged by 54% year-on-year and by 17% since the previous quarter
The company's operating income has surged by 53% YoY and by 18% QoQ
Growth
What is Galecto's growth rate over time
Valuation
What is Galecto stock price valuation
P/E
N/A
P/B
0.3
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GLTO's EPS has surged by 57% year-on-year and by 18% since the previous quarter
GLTO's price to book (P/B) is 63% less than its 5-year quarterly average of 0.8 and 50% less than its last 4 quarters average of 0.6
GLTO's equity is down by 44% year-on-year and by 11% since the previous quarter
Efficiency
How efficient is Galecto business performance
The company's return on invested capital has shrunk by 109% YoY and by 38% QoQ
Galecto's ROE has increased by 15% YoY and by 3.7% from the previous quarter
The return on assets has increased by 6% year-on-year
Dividends
What is GLTO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GLTO.
Financial health
How did Galecto financials performed over time
The current ratio has soared by 131% YoY and by 28% QoQ
The quick ratio has soared by 129% YoY and by 31% from the previous quarter
Galecto's debt is 100% less than its equity
Galecto's debt has plunged by 100% YoY
GLTO's equity is down by 44% year-on-year and by 11% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.